Workplace infection control measures and perceived organizational support during the COVID-19 pandemic in Japan: a prospective cohort study

Abstract

Objective: We investigated whether workplace infection control measures during the COVID-19 pandemic could increase perceived organizational support (POS). Methods: This prospective cohort study was conducted in Japan from December 2020 to December 2021 using a questionnaire survey. There were 18,560 respondents at follow-up; we investigated 4,971 who rated low POS at baseline. The participants were asked a single question about POS and nine about workplace infection control measures. We determined the odds ratios (ORs) of high POS at follow-up using multilevel logistic regression analysis. Results: The groups of 5-6 (OR=1.29; 95% confidence interval [CI], 1.05-1.57; P=0.014) and 7-9 workplace infection control measures (OR=1.54; 95% CI, 1.28-1.85; P<0.001) had significantly higher ORs than the group with 0-2 measures. Conclusions: Health support for employees through workplace infection control measures can increase POS.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported and partly funded by the research grant from the University of Occupational and Environmental Health, Japan (no grant number); Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004); Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), and Hitachi Systems, Ltd. (no grant number) and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan (reference No. R2-079 and R3-006).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data not available due to ethical restrictions

留言 (0)

沒有登入
gif